What did @pissandshit120 actually say?
Honestly, there is not much to work with here. The transcript reads: "I'm just waiting for standing in here, just like a kid, and she's right on his death, on his death." That is the entirety of the spoken content. It is either severely garbled audio, auto-caption failure, or a clip that was cut so aggressively that no coherent claim survives. No medical statement, no GLP-1 reference, no dosing claim, nothing actionable was captured.
The video has 600,000 views and sits in the GLP-1 category, which means the platform or the tagger flagged it as relevant to drugs like semaglutide or tirzepatide. But flagging a category and making a claim are two different things. We cannot fact-check a sentence that does not make a sentence.
Does the science back this up?
There is no claim here to test against the literature. What we can do is note what the science actually says about GLP-1 receptor agonists, since that is the category this video was filed under, and since 600,000 people watched it for some reason.
GLP-1 receptor agonists like semaglutide and tirzepatide have strong clinical trial support for weight reduction and glycemic control. The SURMOUNT-1 trial (Jastreboff et al., 2022, New England Journal of Medicine) showed tirzepatide producing up to 22.5% mean body weight reduction over 72 weeks. The STEP 1 trial (Wilding et al., 2021, NEJM) showed semaglutide at 2.4mg producing roughly 14.9% weight loss versus 2.4% with placebo. These are real, peer-reviewed results from large randomized controlled trials. The drugs work. That is not in dispute.
What is also not in dispute: side effect profiles are significant, access is uneven, compounded versions are not equivalent to branded formulations, and the long-term cardiovascular and oncological data is still accumulating.
What did they get wrong (or right)?
Neither. The transcript contains no falsifiable claim. The creator said something that the caption system rendered as word salad, and we have no way of knowing what they actually meant to communicate. That is not a pass, by the way. A 600,000-view video in a regulated drug category that produces zero legible information is its own kind of problem.
The credit given to @pinofiles in the caption suggests this may be a reaction video or a repurposed clip, which could explain the incoherence. But that does not change what viewers consumed. If someone watched this video expecting GLP-1 guidance and walked away with anything at all, that information came from somewhere other than this transcript, possibly the comments, possibly prior videos, possibly their own projection.
We cannot give credit or assign fault to claims that do not exist in verifiable form. What we can say plainly is that this is not a source anyone should use to make decisions about semaglutide, tirzepatide, or any other regulated medication.
What should you actually know?
GLP-1 receptor agonists are serious medications with real clinical evidence behind them and real risks that require medical supervision. Semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) are FDA-approved for specific indications. They are not interchangeable with compounded peptides, and compounded versions have not undergone the same manufacturing and efficacy review as branded drugs.
Common side effects include nausea, vomiting, gastroparesis-adjacent slowing, and in rare cases pancreatitis. The SELECT trial (Lincoff et al., 2023, NEJM) showed cardiovascular benefit in adults with obesity and established cardiovascular disease, which is meaningful. But that finding applies to the studied drug at the studied dose in the studied population, not to whatever someone is ordering from a compounding pharmacy based on a TikTok video they half-watched.
If you are considering a GLP-1 medication, talk to a licensed clinician. A 600,000-view TikTok with an unreadable transcript is not a substitute for a medical consultation, a prescription, or a safety screening.